ASCO 2024

American Society of Clinical Oncology (ASCO), 2024
May 31-Jun 04, 2024
Chicago, IL

Material Type

Poster
Long-Term Survival Outcomes of Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Brexucabtagene Autoleucel in ZUMA-3
Author: Oluwole, O
Tecartus
Oral Presentation
A Pilot Study of Axicabtagene Ciloleucel in Relapsed/Refractory Primary and Secondary Central Nervous System Lymphomas (PCNSL & SCNSL)
Author: Nayak, L
Yescarta

Call

Kite Medical Information

For product inquiries, adverse events, and products complaints, please call 1-844-454-KITE (1-844-454-5483), Monday-Friday, 5:00am-6:00pm US PST.

Offcanvas title

[contact-form-7 id="508a1ec" title="Submit Medical Inquiry"]